beta-Cryptoxanthin - 1%

CAS : 472-70-8

Ref. 3D-FC158590

Informations sur le produit

• Nom: beta-Cryptoxanthin - 1%
• Synonymes: (1S)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol, (3R)-Cryptoxanthin, (3R)-beta,beta-caroten-3-ol, (3R)-β,β-Caroten-3-ol, (3R)-β-Cryptoxanthin, 3-Hydroxy-β-carotene, Caricaxanthin, Crp 015, Cryptoxanthin, all-trans-, Cryptoxanthine, Cryptoxanthol, Cryptoxanthol, all-trans-, E 161c, Kryptoxanthin, Neo-β-cryptoxanthin, Neocryptoxanthin, all-trans-, Neocryptoxanthol, all-trans-, Paprika carotene, Xanthrophyll 1, all-trans-Cryptoxanthin, all-trans-β-Cryptoxanthin, beta-Cryptoxanthin, trans-Cryptoxanthin, trans-β-Crytoxanthin, β,β-Caroten-3-ol, (3R)-, β-Caroten-3-ol, (R)-all-trans-, β-Cryptoxanthin, β-Cryptoxanthin, all-trans-
• CAS: 472-70-8

Description

Beta-cryptoxanthin is a type of carotenoid that is biosynthesized by plants. Beta-cryptoxanthin is found in oranges, tangerines, and other citrus fruits. It has been shown to increase the metabolic rate and body mass index in mice. Beta-cryptoxanthin also has antioxidant properties that are comparable to vitamin C and E. The biological properties of beta-cryptoxanthin have been studied in vitro using k562 cells and 3t3-l1 preadipocytes. These cells were treated with dehydroascorbic acid (DHA), a metabolite of beta-cryptoxanthin, which increased the production of colony stimulating factor 2 (CSF2) and inhibited the activity of p21 protein kinase. This study suggests that beta-cryptoxanthin may be useful for treating inflammatory diseases such as rheumatoid arthritis or cancer.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 552.87 g/mol
• Formule: C₄₀H₅₆O
• Degré de pureté: Min. 95%